Alfazen-10 Tablets

Alfazen-10 – Alfuzosin 10 mg Extended Release Tablets

Alfazen-10 is an extended-release tablet containing Alfuzosin 10 mg. It belongs to the alpha-adrenergic antagonist class and is used in the management of signs and symptoms associated with benign prostatic hyperplasia (BPH).

What Is Alfazen-10 Used For?

Alfazen-10 is used for the treatment of signs and symptoms of benign prostatic hyperplasia. BPH is a non-cancerous enlargement of the prostate that can cause lower urinary tract symptoms such as difficulty starting urination, weak urinary flow, frequent urination and incomplete emptying of the bladder.

Alfuzosin helps relax smooth muscle in the prostate and bladder neck. This can help improve urinary flow and reduce symptoms associated with urinary obstruction in men with BPH.

Uses of Alfazen-10

Alfazen-10 may be used for:

• Signs and symptoms of benign prostatic hyperplasia
• Difficulty in starting urination associated with BPH
• Weak or reduced urinary flow associated with BPH
• Frequent urination associated with BPH
• Urinary hesitancy associated with BPH
• Incomplete bladder emptying associated with BPH
• Other lower urinary tract symptoms associated with prostate enlargement

How Does Alfazen-10 Work?

Alfuzosin is an alpha-adrenergic antagonist. It works by relaxing smooth muscle in the prostate and bladder neck.

In men with benign prostatic hyperplasia, enlargement of the prostate can contribute to obstruction of urine flow. Relaxation of smooth muscle in the prostate and bladder neck can reduce resistance to urinary flow and help improve symptoms.

Alfuzosin is therefore used to manage the urinary symptoms associated with BPH rather than to reduce the size of the prostate itself.

Benign Prostatic Hyperplasia

Benign prostatic hyperplasia is a common condition in ageing men in which the prostate gland becomes enlarged. The enlargement can place pressure on the urethra and may interfere with normal urinary flow.

Common urinary symptoms can include difficulty beginning urination, weak urine stream, increased urinary frequency, urgency and a feeling that the bladder has not emptied completely.

Alfazen-10 can be used for the symptomatic management of these urinary problems when associated with BPH.

Urinary Flow and BPH

The smooth muscles around the prostate and bladder neck contribute to resistance to urine flow. Alfuzosin helps relax these muscles, which can reduce resistance and support improved urine passage.

The extended-release formulation provides a prolonged-release dosage form designed for once-daily administration according to the prescribed regimen.

Product Information

Brand Name: Alfazen-10
Active Ingredient: Alfuzosin
Strength: 10 mg
Dosage Form: Extended Release Tablets
Therapeutic Segment: Urology
Primary Indication: Benign Prostatic Hyperplasia
Packing: 10 x 10 Tablets

Key Product Highlights

• Alfuzosin 10 mg formulation
• Extended-release tablet dosage form
• Used for signs and symptoms of BPH
• Supports management of lower urinary tract symptoms associated with BPH
• Relevant to urological care
• Suitable for urology-focused pharmaceutical portfolios
• 10 x 10 Tablets presentation

Role in Urological Care

BPH can cause bothersome lower urinary tract symptoms that affect normal urinary function. Pharmacological management may be used to improve urinary symptoms and reduce functional obstruction associated with prostate enlargement.

Alfuzosin provides alpha-adrenergic receptor blockade in the lower urinary tract and helps relax smooth muscle in the prostate and bladder neck.

This makes Alfazen-10 relevant to pharmaceutical portfolios focused on BPH and male urological care.

Important Information

Alfazen-10 is a prescription medicine and should be used under the guidance of a qualified healthcare professional.

The recommended use of alfuzosin extended-release tablets is generally once daily with food and with the same meal each day, according to the approved prescribing information. The extended-release tablet should not be chewed or crushed. :contentReference[oaicite:2]{index=2}

Alfuzosin may cause dizziness, low blood pressure or fainting, particularly when starting treatment or when changing position. Patients should follow medical advice regarding activities such as driving or operating machinery.

Patients should inform their healthcare professional about other medicines they are taking, particularly medicines that may lower blood pressure or medicines that can interact with alfuzosin.

Alfuzosin is not indicated for the treatment of hypertension and is not indicated for use in the pediatric population. :contentReference[oaicite:3]{index=3}

Patients with significant liver problems should inform their healthcare professional before treatment, as alfuzosin extended-release tablets are contraindicated in moderate or severe hepatic impairment. :contentReference[oaicite:4]{index=4}

Storage

Store the product according to the storage conditions mentioned on the approved product label.

Keep the tablets in their original packaging and keep them out of reach of children.

Product Summary

Alfazen-10 contains Alfuzosin 10 mg in an extended-release tablet formulation for the management of signs and symptoms associated with benign prostatic hyperplasia.

Its primary therapeutic positioning is within the Urology segment, particularly for the management of lower urinary tract symptoms associated with BPH.

Alfazen-10 is therefore relevant to urological pharmaceutical portfolios focused on prostate health and urinary symptom management.